Ashley Whitechurch

305 Grattan St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemia.

Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemia.

Journal: Blood advances
Published: April 17, 2026

Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia.

Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia.

Journal: Clinical & translational immunology
Published: February 19, 2025

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial.

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial.

Journal: The Journal of infectious diseases
Published: January 16, 2025

Influenza Vaccination Strategies in Patients with Hematologic Cancer.

Influenza Vaccination Strategies in Patients with Hematologic Cancer.

Journal: The New England journal of medicine
Published: January 15, 2025

A single-institution study of allograft outcomes for chronic lymphocytic leukaemia over 20 years.

A single-institution study of allograft outcomes for chronic lymphocytic leukaemia over 20 years.

Journal: Internal medicine journal
Published: November 26, 2024

Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers.

Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers.

Journal: Clinical and translational science
Published: November 17, 2024

Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial.

Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial.

Journal: JMIR formative research
Published: August 12, 2024

Safety and adherence to medications and self-care advice in oncology (SAMSON): pilot randomised controlled trial protocol.

Safety and adherence to medications and self-care advice in oncology (SAMSON): pilot randomised controlled trial protocol.

Journal: BMJ open
Published: July 23, 2024

Recommendations for innovation in vaccination services for adults with haematological malignancies: an Australian cross-sectional survey study.

Recommendations for innovation in vaccination services for adults with haematological malignancies: an Australian cross-sectional survey study.

Journal: Vaccine
Published: July 22, 2024

"It's a risk-benefit analysis": Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in Australia.

"It's a risk-benefit analysis": Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in Australia.

Journal: Vaccine
Published: January 31, 2024

Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care.

Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care.

Journal: Cancers
Published: December 04, 2023

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.

Journal: Blood advances
Published: July 28, 2023
Showing 1-12 of 16

Last Updated: 09/26/2026